Skip to content
Promedior logo

Promedior Alternatives & Competitors

12 companies similar to Promedior — Pioneering advanced therapies to heal fibrotic and inflammatory diseases at thei...

Companies similar to Promedior

Certa Therapeutics logo — alternative to Promedior

Certa Therapeutics

Developing innovative precision therapies for the treatment of inflammatory and fibrotic d...

Dianthus Therapeutics, Inc. logo — alternative to Promedior

Dianthus Therapeutics, Inc.

Building a leading biotech company focused in severe autoimmune diseases.

AnaptysBio logo — alternative to Promedior

AnaptysBio

Transforming patient health by delivering innovative immunology therapeutics.

Flame Biosciences logo — alternative to Promedior

Flame Biosciences

A clinical-stage pioneer focused on discovering, developing, and commercializing groundbre...

Rival Readout

Competing with Promedior? We do this properly.

10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.

Book a 7-day Readout
Angion logo — alternative to Promedior

Angion

Angion is committed to transforming the treatment paradigm for patients suffering from fib...

Nimbus Therapeutics logo — alternative to Promedior

Nimbus Therapeutics

We develop breakthrough medicines for patients through precision small molecule design.

Molecure logo — alternative to Promedior

Molecure

Fate can be altered.

Solu Therapeutics logo — alternative to Promedior

Solu Therapeutics

Solu Therapeutics is a next-generation therapeutics focused company working to eliminate c...

Inversago Pharma logo — alternative to Promedior

Inversago Pharma

Pioneering innovative therapies to enhance the lives of patients with metabolic and fibrot...

Palatin Technologies logo — alternative to Promedior

Palatin Technologies

We discover and develop novel therapeutics for patients living with inflammatory and autoi...

Avalo Therapeutics logo — alternative to Promedior

Avalo Therapeutics

Innovation driven by compassion.

Enlivex Therapeutics (Nasdaq: ENLV) logo — alternative to Promedior

About Promedior

Promedior is a biopharmaceutical startup founded in 2006, focused on developing innovative treatments for inflammatory and fibrotic diseases. The company's unique drug discovery platform targets monocyte-derived cell populations critical in fibrotic, inflammatory, and autoimmune conditions, directly addressing the root...

Business keywords

Biopharmaceutical, Drug Discovery, Therapeutics, Fibrotic Diseases, Inflammatory Diseases, Clinical-stage, Monocyte-derived Cell Populations, Immunotherapy, Tissue Healing, Precision Medicine, Autoimmune Conditions, Eye Diseases, Lung Diseases, Kidney Diseases, Novel Therapeutics

Frequently Asked Questions

Companies similar to Promedior include Certa Therapeutics, Dianthus Therapeutics, Inc., AnaptysBio, Flame Biosciences, Angion. They work in Biotechnology and Health and Wellness and share Promedior's focus on inflammatory diseases, precision medicine and clinical-stage.
Bounce Watch lists 12 companies that share Promedior's industries and are closest to it in business tags, services, target customers, business model and size.
Promedior is a biopharmaceutical startup founded in 2006, focused on developing innovative treatments for inflammatory and fibrotic diseases. The company's unique drug discovery platform targets monocyte-derived cell populations critical in fibrotic, inflammatory, and autoimmune conditions, directly addressing the root...

From the desk

Mapping a market? Start with a Rival Readout.

In 7 business days we read 10 rivals around Promedior: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.

Compiled from the BounceWatch company index. We last looked at Promedior on 12 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout